← Leaderboards
Catherine H Charles
Perlan Therapeutics, Inc.
$809,158
Attributed
$809,158
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $300K · FY2007–08$500K$375K$250K$125K$0
'07
'08
Funding mix
By agency
NIH$809,158 · 2
By mechanism
R43$599,934 · 1
R44$209,224 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Government”
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- David Heimbrook · Leidos Biomedical Research, Inc.$282,527,481
- Judith S. Currier · University Of California Los Angeles$272,240,505
- Valerie Koch · University Corporation For Atmospheric Res$252,793,840
- Everette D Joseph · Howard University$252,793,840
Research focus
GovernmentHemagglutininEstersFutureGrantAnimalsBiodegradable PolymerAmidesAchievementFormulations, DrugAntigens, ViralCommercializationBaseConceptConditionCostCouplingAntibody FormationDosageAntigensDoseClinical ImmunologyClinical TrialsHuman Disease
Grant awards (3)
IMMUNOGENICITY TESTING OF A FULLY SYNTHETIC SUBUNIT VACCINE AGAINST INFLUENZA$299,940
R43 · FY2008 · AI · contact PI
IMMUNOGENICITY TESTING OF A FULLY SYNTHETIC SUBUNIT VACCINE AGAINST INFLUENZA$299,994
R43 · FY2007 · AI · contact PI
Development of ColdSol TMfor Rhinovirus Infections$209,224
R44 · FY2003 · AI